Dr. Michael Ackerman, a genetic cardiologist and professor at Mayo Clinic, joins the discussion on channelopathies. They dive into Brugada syndrome and the critical role of genetic testing and family screening in diagnosis. The conversation extends to long QT syndrome, emphasizing tailored treatment strategies based on specific genetic profiles. Additionally, the potential of AI in improving the diagnosis and management of these conditions is explored, spotlighting advancements that enhance patient care through accurate data integration.